Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study

Carlos Mario Balcázar-Valencia, Andrés Felipe García-Ramos, Luis Miguel Osorio-Toro, Yessica Alejandra Ordoñez-Guzmán, Nathalia Buitrago-Gómez, William Fernando Cabarcas-López, Carlos Javier Vizcaino-Guerrero, Jorge Enrique Daza-Arana, Alex Ramírez-Rincón, Katherine Restrepo-Erazo

Producción científica: Contribución a una revistaArtículo en revista científica indexadarevisión exhaustiva

Resumen

Purpose: Diabetes is a public health problem that requires strategies to impact glycemic control and reduce the risk of long-term medical complications. Pharmacological management is a necessary treatment for this disease. Therefore, semaglutide is an essential tool to achieve the treatment targets. The present study aimed to evaluate the semaglutide effects on a cohort with type 2 diabetes mellitus (T2DM) in Colombia. Materials and Methods: The cohort included 49 patients with T2DM that have been treated in a specialized care center. Their glycemic outcomes, weight, renal function, and adverse events were evaluated through a 3-, 6-and 12-month follow-up. Results: Significant differences were observed in the outcome evaluation: reduction of glycated hemoglobin levels (MD −2.74 CI −1.95 to −3.52 in 6 months), fasting plasma glucose levels, body weight (MD −7.11 CI −5.97 to −8.24), and the albumin-to-creatinine ratio. The results were maintained throughout the treatment period. The adverse event rate was 16.3%, predominating gastrointestinal events. Conclusion: This real-world evidence shows the efficacy of semaglutide in achieving treatment goals in patients with T2DM.
Idioma originalInglés
Páginas (desde-hasta)1667-1673
Número de páginas7
PublicaciónDiabetes, Metabolic Syndrome and Obesity
Volumen17
DOI
EstadoPublicada - 2024

Nota bibliográfica

Publisher Copyright:
© 2024 Balcázar-Valencia et al.

Tipos de Productos Minciencias

  • Artículos de investigación con calidad A2 / Q2

Huella

Profundice en los temas de investigación de 'Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study'. En conjunto forman una huella única.

Citar esto